ArtJen Releases Impressive Weight Loss Data At International Obesity Meeting

ArtJen Complexus Holdings Corp. released data from their double-blind, placebo controlled clinical trial of FBCx for weight loss and weight management at the annual meeting of the North American Association for the Study of Obesity (NAASO) in Vancouver, BC, October 15 through 19, 2005. The new invention works well in obese individuals and for people with diabetes that need to lose weight.
K-L Catherine Jen, Ph.D., George Grunberger, M.D., and Joseph Artiss, Ph.D. presented data from their clinical trial on volunteers with type 2 diabetes. Important conclusions to the Clinical Study include:
FBCx is effective in reducing and/or maintaining body weight in patients with type 2 diabetes.
FBCx is effective in reducing blood lipid levels in patients with elevated blood triglycerides.
FBCx can be easily incorporated into diabetes management regimen.
FBCx was shown to bind 9.7 times its own weight in dietary fat in human volunteers.
Dr Grunberger, of the renowned Grunberger Diabetes Institute, in Michigan, states that: “About 90 % of his patients with type 2 diabetes are obese and obesity is the number 2 preventable cause of death in the U.S.” Before FBCx became available, “There was no known effective way to keep weight off.” Said Dr Grunberger “This discovery, which can help shed pounds or prevent weight gain is real progress.”
The co-inventors of FBCx are professors Joe Artiss, Ph.D. and Cathy Jen, Ph.D. both of Wayne State University in Detroit, Michigan. “FBCx is the first new approach to weight loss, effective for diabetics and others” said Dr Artiss. Dr Jen said “Unlike claims made by others, this product actually works.” Dr Artiss, who lives in Canada, points out the FBCx is available in both Canada and the United States.
The important results of this clinical trial could change the face of dietary management in patients with type 2 diabetes. Subjects in preclinical trials, including non diabetic patients showed dramatic and consistent weight loss. Many reported significant weight loss in the first few weeks and over 40 pounds of weight loss have been recorded. Employing a natural fiber each 1 gram tablet binds more than 9 grams of dietary fat effectively preventing the fat from being absorbed by the body. Dr. Artiss said: “There’s too much information to go into detail here but there’s full scientific information available at the educational website we set up: www.artJen.net .
By taking the recommended 2 tablets per typical North American meal results in a weight loss of 1 to 1.5 pounds per week. The product is now available under the FBCx name, Fat Binding Complexer. A US patent has been awarded to the ArtJen Company for FBCx. Detailed information, as well as product availability, is now available for the first time at the educational website www.artjen.net .
For further information contact Joe at 1-519-919-0814 or by e-mail joe@artjen.net.